Role of Adenosine 3',5'-cyclic Monophosphate in Adrenoceptor-mediated Control of 3H-noradrenaline Secretion in Guinea-pig Ileum Myenteric Nerve Terminals

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1985 Aug 1

PMID 2413372

Citations 10

Authors

P Alberts

V R Ogren

A I Sellstrom

Affiliations

Soon will be listed here.

Abstract

Secretion of 3H-noradrenaline was evoked by electrical field stimulation (1 Hz, 300 shocks) in guinea-pig ileum myenteric plexus. The role of cyclic nucleotides in the presynaptic receptor-mediated control of 3H-noradrenaline secretion was studied. The secretion of 3H-noradrenaline was maximally enhanced to the same extent, viz. 300-400% of control, by two analogues of cyclic AMP (8-Br cyclic AMP and dibutyryl cyclic AMP), by an adenylate cyclase activator (forskolin) and by three structurally different inhibitors of phosphodiesterase (3-isobutyl-1-methylxanthine, SQ 20,006 and Ro 20-1724), but not altered by two analogues of cyclic GMP (8-Br cyclic GMP and dibutyryl cyclic GMP). Added separately an alpha 2-adrenoceptor antagonist (yohimbine) and a beta-adrenoceptor agonist (isoprenaline) enhanced the 3H-noradrenaline secretion. Yohimbine, but not isoprenaline, increased additively the 'maximal enhancement' of the 3H-noradrenaline secretion caused by 3-isobutyl-1-methylxanthine. These results suggest that neuronal cyclic AMP may be involved in beta- but not in alpha-adrenoceptor-mediated control of 3H-noradrenaline secretion in guinea-pig ileum myenteric nerve terminals.

Citing Articles

Effects of cyclic GMP and analogues on neurogenic transmission in the rat tail artery.

Ouedraogo S, Tschopl M, STOCLET J, Bucher B Br J Pharmacol. 1994; 112(3):867-72.

PMID: 7921614 PMC: 1910191. DOI: 10.1111/j.1476-5381.1994.tb13160.x.

Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria.

Johnston H, Majewski H, Musgrave I Br J Pharmacol. 1987; 91(4):773-81.

PMID: 3664078 PMC: 1853579. DOI: 10.1111/j.1476-5381.1987.tb11275.x.

Pertussis toxin does not attenuate alpha 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria.

Musgrave I, Marley P, Majewski H Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(3):280-6.

PMID: 2891042 DOI: 10.1007/BF00172679.

Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, beta-adrenoceptors and angiotensin II receptors.

Costa M, Majewski H Br J Pharmacol. 1988; 95(3):993-1001.

PMID: 2850068 PMC: 1854244. DOI: 10.1111/j.1476-5381.1988.tb11730.x.

Protein kinase C activation increases noradrenaline release from the rat hippocampus and modifies the inhibitory effect of alpha 2-adrenoceptor and adenosine A1-receptor agonists.

Fredholm B, Lindgren E Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(5):477-83.

PMID: 2842695 DOI: 10.1007/BF00182719.

References

WILKINSON G . Statistical estimations in enzyme kinetics. Biochem J. 1961; 80:324-32. PMC: 1244002. DOI: 10.1042/bj0800324. View

Stjarne L, Alberts P . Influence of temperature on stimulus-secretion coupling in the sympathetic nerves and on neuromuscular transmission, in guinea-pig vas deferens. Acta Physiol Scand. 1985; 125(2):181-94. DOI: 10.1111/j.1748-1716.1985.tb07706.x. View

Nathanson J . Cyclic nucleotides and nervous system function. Physiol Rev. 1977; 57(2):157-256. DOI: 10.1152/physrev.1977.57.2.157. View

SHEPPARD H, Wiggan G . Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase. Mol Pharmacol. 1971; 7(1):111-5. View

Hughes J . Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline. Br J Pharmacol. 1973; 47(2):428-30. PMC: 1776551. DOI: 10.1111/j.1476-5381.1973.tb08342.x. View

Seamon K, Daly J . Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981; 7(4):201-24. View

Alberts P . Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves. Acta Physiol Scand Suppl. 1982; 506:1-39. View

Cavero I, Shepperson N, Langer S . Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil. Circ Res. 1983; 52(2 Pt 2):I69-76. View

Alberts P, Bartfai T, Stjarne L . Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens. J Physiol. 1981; 312:297-334. PMC: 1275555. DOI: 10.1113/jphysiol.1981.sp013630. View

10.

Fredholm B, Persson C . Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol. 1982; 81(4):673-6. DOI: 10.1016/0014-2999(82)90359-4. View

11.

Fredholm B, Hedqvist P . Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol. 1980; 29(12):1635-43. DOI: 10.1016/0006-2952(80)90117-3. View

12.

Schoffelmeer A, Mulder A . 3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol. 1983; 323(3):188-92. DOI: 10.1007/BF00497661. View

13.

Chasin M, HARRIS D, Phillips M, HESS S . 1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases. Biochem Pharmacol. 1972; 21(18):2443-50. DOI: 10.1016/0006-2952(72)90414-5. View

14.

Gothert M . Adrenergic transmitter release. Blood Vessels. 1984; 21(3):117-25. View

15.

Vizi E . Presynaptic modulation of neurochemical transmission. Prog Neurobiol. 1979; 12(3-4):181-290. DOI: 10.1016/0301-0082(79)90011-x. View

16.

Bartfai T . Cyclic nucleotides in the central nervous system. Curr Top Cell Regul. 1980; 16:225-69. DOI: 10.1016/b978-0-12-152816-4.50011-x. View

17.

Markstein R, Digges K, Marshall N, Starke K . Forskolin and the release of noradrenaline in cerebrocortical slices. Naunyn Schmiedebergs Arch Pharmacol. 1984; 325(1):17-24. DOI: 10.1007/BF00507049. View

18.

Muneyama K, Bauer R, Shuman D, ROBINS R, Simon L . Chemical synthesis and biological activity of 8-substituted adenosine 3',5'-cyclic monophosphate derivatives. Biochemistry. 1971; 10(12):2390-5. DOI: 10.1021/bi00788a033. View

19.

Beavo J, Rogers N, Crofford O, Hardman J, SUTHERLAND E, NEWMAN E . Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase activity. Mol Pharmacol. 1970; 6(6):597-603. View

20.

Furness J, Costa M . Types of nerves in the enteric nervous system. Neuroscience. 1980; 5(1):1-20. DOI: 10.1016/0306-4522(80)90067-6. View